World’s first iPS cell-based treatment set to debut as early as this summer iPS 細胞の再生医療２製品、世界初承認へ 心不全とパーキンソン病の治療での実用化めざす
Lab-grown heart made from induced pluripotent stem (iPS) cells is pictured during a media day ahead of public opening day of the Expo 2025 in Osaka, 2025. (Reuters/file)
An expert panel at the health ministry greenlit the domestic manufacturing and marketing of two regenerative medical products that use induced pluripotent stem (iPS) cells on Feb. 19.
The health minister will grant formal approval at a later date.
When approved, they will be the world’s first prac...
